Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party - Koenecke, C.; Heim, D.; van Biezen, A.; Heuser, M.; Aljurf, M.; Kyrcz-Krzemien, S.; Volin, L.; de Souza, C. A.; Gedde-Dahl, T.; Sengeloev, H.; Schanz, U.; Komarnicki, M.; et al. (Bone Marrow Transplantation, 2016)